Healthcare

IPD, MX1 & MDR: Three ASX health tech stocks with strong revenue in...

May 04, 2022 11:27 AM AEST | By Aditi Sarkar

Highlights ImpediMed saw record results for total revenue and SOZO SaaS revenue in Q3. Micro-X achieved good growth in Mobile DR unit sales with e...

AGN, PYC, KZA: An insight into key highlights of healthcare therapeu...

May 02, 2022 12:30 PM AEST | By Aditi Sarkar

Highlights AGN continued preclinical work targeting the potential use of ARG-007 in other kinds of brain injuries PYC initiated GLP toxicology stu...

BOD (ASX:BOD) shares gain attention on quarterly update

April 29, 2022 04:15 PM AEST | By Samta

Highlights BOD Australia has made solid progress towards the commencement of clinical trials and product commercialisation. Cannabis sales incre...

ResMed (ASX:RMD) revenue takes strong leap in FY22 third quarter

April 29, 2022 12:18 PM AEST | By Ritwika

Highlights: ResMed released its unaudited Q3 FY22 results today, stating a 14% gain in revenue.  ResMed’s earnings per share stand at A...

Why is Starpharma (ASX:SPL) in news today?

April 29, 2022 12:02 PM AEST | By Sonal Goyal

Highlights: Starpharma is working closely with LloydsPharmacy to bring VIRALEZE back in the UK by this quarter. Starpharma has recorded AU$3.6 mil...

DXB, AT1, JTL: How did these healthcare penny stocks fare in March q...

April 28, 2022 08:07 PM AEST | By Aditi Sarkar

Highlights Penny stocks are generally priced below one dollar DXB has received the Orphan Drug Designation for DMX 200 in both the US and Europe...

Life360 Inc’s (ASX: 360) subscription revenue rises 63% in FY22

April 27, 2022 07:34 PM AEST | By Aditi Saha

Highlights With a 43% yoy (year-on-year) increase in paying circles and a 63% yoy (year-on-year) growth in subscription revenue, Life360’s ma...

Actinogen gets upbeat results from Xanamem trial for Alzheimer’s tre...

April 27, 2022 07:28 PM AEST | By Aditi Sarkar

Highlights Actinogen Medical receives encouraging results for XanaMIA Part A trial for its lead compound Xanamem The results confirm the potential...

Jatcorp (ASX: JAT) reports strong revenue growth in March quarter

April 26, 2022 07:42 PM AEST | By Aditi Sarkar

Highlights The ease in pandemic restrictions has put Jatcorp in an excellent position to reap the benefits of investments made since 2020 The co...

PolyNovo (ASX:PNV) charged up on record revenue in March quarter

April 06, 2022 06:25 PM AEST | By Sonal Goyal

Highlights PolyNovo has delivered a return of AU$12.26 million in the March quarter. Proceeds for the Lorimer Street property sale is expected in...

ACW, IHL & CGS: ASX healthcare penny stocks with over 150% returns i...

April 06, 2022 02:56 PM AEST | By Aditi Sarkar

Highlights Penny stocks have strong potential to yield lucrative rewards. They are extremely volatile; thus, investors should do proper due dilige...

MX1, MDR, and OSX: Medical technology stocks from ASX

April 06, 2022 12:43 PM AEST | By Aditi Sarkar

Highlights Products, services, and solutions used in the medical field are known as medical technologies Pregnancy tests and X-rays are one of the...

BGH intends to make new Virtus (ASX:VRT) bid at AU$8 cash per share

April 06, 2022 11:54 AM AEST | By Priyanka Payal

Highlights BGH Capital is considering making an off-market takeover offer to acquire all fully paid ordinary shares (Shares) in Virtus Health Limit...

All you need to know about the S&P/ASX 200 Health Care

April 05, 2022 01:58 PM AEST | By Aditi Sarkar

Highlights Indices are benchmark and a standard reference point for the entire stock market Comparison with an index gives an easy assessment of a...

What about the Cyber Security bill is ailing private hospitals?

April 04, 2022 12:50 PM AEST | By Aditi Sarkar

Highlights According to the new Cyber Security Bill proposed in Australia, private hospitals with Intensive Care Units must comply with cyber secur...

Anatara Life Sciences (ASX: ANR) swiftly progresses its clinical tri...

April 01, 2022 07:25 PM AEDT | By Aditi Sarkar

Highlights Anatara Lifesciences is advancing well in its clinical trials in psychological functioning and irritable bowel syndrome, diarrhoea subty...